Is SCNI or SRRK more undervalued in 2026?

CirclFi compares Scinai Immunotherapeutics Ltd. (SCNI) and Scholar Rock Holding Corporatio (SRRK) using 13 institutional-grade valuation models. SCNI has a Quality of Company score of 1.9/10 while SRRK scores 5.1/10.

Which is a better buy — SCNI or SRRK?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SCNI and SRRK valuations compare?

SCNI at $0.45 and SRRK at $49.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SCNI vs SRRK Valuation Comparison 2026 — Intrinsic Value Analysis

SCNI

Biological Products, (No Diagnostic Substances)

Scinai Immunotherapeutics Ltd.

Quality

1.9

out of 10

Value Trap

SAFE

Price

$0.45

Last close

Models

9/13

Active

SRRK

Biological Products, (No Diagnostic Substances)

Scholar Rock Holding Corporatio

Quality

5.1

out of 10

Value Trap

LOW

Price

$49.82

Last close

Models

10/13

Active

Model-by-Model Comparison

Model	Type	SCNI Fair Value	SCNI Upside	SRRK Fair Value	SRRK Upside
Bayesian DCF	Intrinsic	$0.12	-72.3%	$15.50	-68.9%
Earnings Power Value	Intrinsic	—	—	$21.36	-54.0%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$0.05	-88.2%	—	—
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SCNI vs SRRK — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SCNI vs SRRK — Which Stock Is More Undervalued?

SRRK scores higher with a 5.1/10 quality rating vs SCNI's 1.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Scinai Immunotherapeutics Ltd. (SCNI) and Scholar Rock Holding Corporatio (SRRK) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SCNI currently trades at $0.45 with a QOC of 1.9/10, while SRRK trades at $49.82 with a QOC of 5.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).